EMERCell signs strategic partnership with Onward Therapeutics


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ EMERCell signs strategic partnership with Onward Therapeutics
EMERCell signs strategic partnership with Onward Therapeutics for the development of its NK cell therapy technology

EMERCell, a biotechnology company developing immunotherapies and cell-based therapies for oncology targets through to pharmaceutical development, announces the signature of a strategic partnership with Onward Therapeutics. The significant investment, of a confidential amount, will be made in three instalments that will allow EMERCell to reach the first human clinical trials.

"We are delighted to partner with Onward Therapeutics, whose teams have recognized expertise in the development of new drugs in oncology and with whom we have strong synergies. Their participation is a recognition of our expertise and will allow us to accelerate our development," said Patrick Henno, founder and Chairman of EMERCell.

“We are pleased to collaborate with EMERCell to scale up their patented process of activation and amplification of the allogeneic NK cells for clinical development,” said Dr C. Grace Yeh, Chairman and CEO of Onward. “Accessing to the highly activated NK cells allows Onward to explore their potentials for improved efficacy in the immunotherapy for cancer patients.”

During the last few years, EMERCell, with the support of the Italian company Bioline diagnostici, has developed and patented, in partnership with the University Hospital of Montpellier, the University of Montpellier and Inserm, a process for the production of a therapeutic tool composed of NK cells. EMERCell is now focusing on the development of its first product, NK-001, a new innovative therapy drug (ATMP) for the treatment of cancer.

Tags : #EMERCell #OnwardTherapeutics #LatestPharmaCollaboration18thFeb #LatestPharmaNews18thFeb #TreatmentofCancer #BiolineDiagnostici

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026